← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2019-1:376 | 376 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Calcium Gluconate; Zinc Sulfate Anhydrous; Magnesium Chloride Anhydrous | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:376 | 376 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-605 | 70004-605-09 | Ephedrine Sulfate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:376 | 376 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:376 | 376 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:376 | 376 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-615 | 68985-615-91 | Diltiazem Hydrochloride | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:376 | 376 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6003 | 71286-6003-2 | Ephedrine Sulfate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:376 | 376 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2090 | 70168-2090-1 | Estradiol | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:376 | 376 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-3720 | 72682-3720-1 | Estradiol | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:376 | 376 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-373 | 73693-373-01 | Estradiol | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:376 | 376 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2207 | 72627-2207-9 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:376 | 376 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-3722 | 72682-3722-1 | Estradiol | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:376 | 376 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:376 | 376 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:376 | 376 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-103 | 73177-103-05 | Fentanyl Citrate | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:376 | 376 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:377 | 377 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9080 | 71266-9080-4 | Ketamine | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:377 | 377 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70360-012 | 70360-012-77 | Cantharidin | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:377 | 377 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:377 | 377 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70324-152 | 70324-152-01 | Epinephrine | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:377 | 377 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:377 | 377 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diltiazem Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:377 | 377 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6004 | 71286-6004-1 | Ephedrine Sulfate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:377 | 377 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79559-3012 | 79559-3012-1 | Estradiol | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:377 | 377 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2109 | 72627-2109-3 | Estradiol Cypionate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:377 | 377 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-376 | 73693-376-01 | Estradiol | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:377 | 377 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2208 | 72627-2208-9 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:377 | 377 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-3706 | 72682-3706-1 | Estradiol | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:377 | 377 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:377 | 377 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:377 | 377 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-103 | 73177-103-28 | Fentanyl Citrate | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:377 | 377 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:378 | 378 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-392 | 69194-392-01 | 392 CALCIUM GLUCONATE 1% BAG | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:378 | 378 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 62295-5002 | 62295-5002-5 | Cantharidin | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:378 | 378 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:378 | 378 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70324-077 | 70324-077-01 | Epinephrine | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:378 | 378 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:378 | 378 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70324-976 | 70324-976-01 | Diltiazem Hydrochloride | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:378 | 378 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-604 | 70004-604-12 | Ephedrine Sulfate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:378 | 378 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2080 | 70168-2080-1 | Estradiol | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:378 | 378 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-201 | 73702-201-10 | Fentanyl | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:378 | 378 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-377 | 73693-377-01 | Estradiol | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:378 | 378 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2209 | 72627-2209-9 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:378 | 378 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-378 | 73693-378-01 | Estradiol | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:378 | 378 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:378 | 378 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5010 | 71266-5010-1 | Fentanyl Citrate | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:378 | 378 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-101 | 63037-101-05 | Fentanyl Citrate | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:378 | 378 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:379 | 379 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-202 | 81375-202-10 | Tropicamide/Phenylephrine Sterile Ophthalmic Solution | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:379 | 379 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cantharidin | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:379 | 379 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:379 | 379 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:379 | 379 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70731-201 | 70731-201-85 | Ephedrine Sulfate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:379 | 379 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70324-951 | 70324-951-01 | Diltiazem Hydrochloride | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:379 | 379 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-605 | 70004-605-09 | Ephedrine Sulfate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:379 | 379 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2109 | 72627-2109-3 | Estradiol Cypionate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:379 | 379 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-202 | 73702-202-15 | Fentanyl | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:379 | 379 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-370 | 73693-370-01 | Estradiol | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:379 | 379 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-375 | 73693-375-01 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:379 | 379 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0020 | 73271-0020-1 | Estradiol | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:379 | 379 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:379 | 379 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5040 | 71266-5040-1 | Fentanyl Citrate | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:379 | 379 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-100 | 63037-100-05 | Fentanyl Citrate | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:379 | 379 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-694 | 70092-694-43 | Fentanyl Citrate | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:380 | 380 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6523 | 72934-6523-2 | Mavilo | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:380 | 380 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0572 | 5446-0572-03 | Cantharidin | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:380 | 380 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:380 | 380 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70324-027 | 70324-027-01 | Epinephrine | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:380 | 380 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1350 | 61141-1350-5 | Ephedrine Sulfate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:380 | 380 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7090 | 71285-7090-1 | Diphenhydramine Hydrochloride | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:380 | 380 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:380 | 380 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5553 | 26436-5553-1 | Estriol; Estradiol | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:380 | 380 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-202 | 73702-202-02 | Fentanyl | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:380 | 380 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-371 | 73693-371-01 | Estradiol | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:380 | 380 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-371 | 73693-371-01 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:380 | 380 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0022 | 73271-0022-1 | Estradiol | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:380 | 380 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9170 | 71266-9170-5 | Fentanyl Citrate | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:380 | 380 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:380 | 380 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:380 | 380 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:381 | 381 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-161 | 82396-161-05 | Neostigmine Methylsulfate | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:381 | 381 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 62295-5004 | 62295-5004-5 | Cantharidin; Podophyllum Resin; Salicylic Acid | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:381 | 381 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:381 | 381 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-811 | 76154-811-15 | Epinephrine | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:381 | 381 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-107 | 73702-107-15 | Ephedrine Sulfate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:381 | 381 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7089 | 71285-7089-1 | Diphenhydramine Hydrochloride | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:381 | 381 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-604 | 70004-604-09 | Ephedrine Sulfate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:381 | 381 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5423 | 26436-5423-1 | Estriol; Testosterone; Estradiol | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:381 | 381 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-202 | 73702-202-03 | Fentanyl | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:381 | 381 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-375 | 73693-375-01 | Estradiol | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:381 | 381 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-373 | 73693-373-01 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:381 | 381 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2020 | 70168-2020-1 | Estradiol | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:381 | 381 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9170 | 71266-9170-6 | Fentanyl Citrate | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:381 | 381 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:381 | 381 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:381 | 381 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83863-6030 | 83863-6030-1 | Fentanyl Citrate | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:382 | 382 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-244 | 71170-244-25 | Vancomycin 750mg added to 250mL of 0.9% Sodium Chloride | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:382 | 382 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 62295-5004 | 62295-5004-7 | Cantharidin; Podophyllum Resin; Salicylic Acid | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:382 | 382 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:382 | 382 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-812 | 76154-812-15 | Epinephrine | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:382 | 382 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9025 | 71266-9025-5 | Ephedrine Sulfate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:382 | 382 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 62295-3060 | 62295-3060-5 | Diphenhydramine Hydrochloride; Magnesium Hydroxide; Aluminum Hydroxide; Dimethicone; Lidocaine Hydrochloride | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:382 | 382 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:382 | 382 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70214-3020 | 70214-3020-1 | Fentanyl | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:382 | 382 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-204 | 73702-204-25 | Fentanyl | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:382 | 382 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2050 | 70168-2050-1 | Estradiol | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:382 | 382 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-376 | 73693-376-01 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:382 | 382 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0015 | 73271-0015-1 | Estradiol | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:382 | 382 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1016 | 73013-1016-1 | Fentanyl Citrate | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:382 | 382 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-100 | 63037-100-05 | Fentanyl Citrate | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:382 | 382 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-098 | 70092-098-44 | Fentanyl Citrate | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:382 | 382 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:383 | 383 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-389 | 73693-389-01 | TESTOSTERONE 25 MG | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:383 | 383 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cefazolin Sodium | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:383 | 383 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:383 | 383 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-815 | 76154-815-15 | Epinephrine | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:383 | 383 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:383 | 383 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Disodium Nicotinamide Adenine Dinucleotide | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:383 | 383 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-106 | 71449-106-15 | Ephedrine Sulfate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:383 | 383 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:383 | 383 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70214-3020 | 70214-3020-1 | Fentanyl | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:383 | 383 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2030 | 70168-2030-1 | Estradiol | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:383 | 383 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-377 | 73693-377-01 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:383 | 383 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0006 | 73271-0006-1 | Estradiol | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:383 | 383 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1065 | 73013-1065-1 | Fentanyl Citrate | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:383 | 383 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83863-9010 | 83863-9010-2 | Fentanyl Citrate | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:383 | 383 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-509 | 70092-509-35 | Fentanyl Citrate | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:383 | 383 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:384 | 384 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-152 | 69194-152-01 | 152 CALCIUM GLUCONATE 2.5% SYRINGE | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:384 | 384 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cefazolin Sodium | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:384 | 384 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:384 | 384 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70324-052 | 70324-052-01 | Epinephrine | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:384 | 384 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:384 | 384 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Doxycycline Hyclate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:384 | 384 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-106 | 71449-106-11 | Ephedrine Sulfate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:384 | 384 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-202 | 73702-202-15 | Fentanyl | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:384 | 384 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70214-5010 | 70214-5010-1 | Fentanyl | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:384 | 384 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-061 | 69761-061-01 | Estradiol | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:384 | 384 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-370 | 73693-370-01 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:384 | 384 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0018 | 73271-0018-1 | Estradiol | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:384 | 384 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:384 | 384 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:384 | 384 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-444 | 70092-444-05 | Fentanyl Citrate | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:384 | 384 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:385 | 385 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0431 | 71285-0431-1 | Trophamine 3.5%/Dextrose 10% and Heparin 125 units 250ml bag | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:385 | 385 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cefazolin Sodium | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:385 | 385 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:385 | 385 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8110 | 71266-8110-1 | Epinephrine | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:385 | 385 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-106 | 73702-106-10 | Ephedrine Sulfate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:385 | 385 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Doxycycline Hyclate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:385 | 385 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-6643 | 71139-6643-1 | Ephedrine Sulfate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:385 | 385 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-202 | 73702-202-02 | Fentanyl | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:385 | 385 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:385 | 385 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-121 | 69761-121-01 | Estradiol | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:385 | 385 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-050 | 70713-050-01 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:385 | 385 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0050 | 73271-0050-1 | Estradiol | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:385 | 385 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:385 | 385 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:385 | 385 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-099 | 70092-099-49 | Fentanyl Citrate | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:385 | 385 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:386 | 386 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1400 | 72934-1400-2 | Aveidaoxia | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:386 | 386 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cefazolin Sodium | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:386 | 386 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:386 | 386 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-7018 | 72196-7018-1 | Epinephrine | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:386 | 386 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8110 | 71266-8110-1 | Epinephrine | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:386 | 386 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Doxycycline Hyclate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:386 | 386 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1350 | 61141-1350-5 | Ephedrine Sulfate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:386 | 386 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-202 | 73702-202-03 | Fentanyl | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:386 | 386 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70324-327 | 70324-327-01 | Fentanyl | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:386 | 386 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2100 | 70168-2100-1 | Estradiol | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:386 | 386 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-145 | 70713-145-01 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:386 | 386 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2010 | 70168-2010-1 | Estradiol | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:386 | 386 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:386 | 386 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:386 | 386 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-097 | 70092-097-43 | Fentanyl Citrate | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:386 | 386 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-886 | 69194-886-01 | Fentanyl Citrate | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:387 | 387 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9065 | 83826-9065-0 | Tropicamide, Phenylephrine HCl | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:387 | 387 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cefazolin Sodium | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:387 | 387 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:387 | 387 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-7019 | 72196-7019-1 | Epinephrine | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:387 | 387 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70324-052 | 70324-052-01 | Epinephrine | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:387 | 387 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Dyclonine Hydrochloride; Lidocaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:387 | 387 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1374 | 61141-1374-5 | Ephedrine Sulfate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:387 | 387 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-204 | 73702-204-25 | Fentanyl | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:387 | 387 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2080 | 71286-2080-2 | Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:387 | 387 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2060 | 70168-2060-1 | Estradiol | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:387 | 387 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-378 | 73693-378-01 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:387 | 387 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-373 | 73693-373-01 | Estradiol | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:387 | 387 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:387 | 387 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9170 | 71266-9170-5 | Fentanyl Citrate | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:387 | 387 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:387 | 387 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-101 | 63037-101-10 | Fentanyl Citrate | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:388 | 388 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0431 | 72196-0431-1 | Trophamine 3.5%/Dextrose 10% and Heparin 125 units 250ml bag | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:388 | 388 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cefazolin Sodium | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:388 | 388 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:388 | 388 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:388 | 388 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-812 | 76154-812-15 | Epinephrine | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:388 | 388 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Dyclonine Hydrochloride; Lidocaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:388 | 388 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:388 | 388 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-203 | 73702-203-02 | Fentanyl | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:388 | 388 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-910 | 71170-910-25 | Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-15 |